Pelago Bioscience
Pelago Bioscience supports drug discovery teams with proprietary CETSA® technology, generating biologically relevant insights through direct cellular target engagement. In 2026, Pelago Bioscience acquired RG Discovery, broadening its offering with specialist chemistry expertise. Its expanded capabilities help teams make better-informed decisions, reduce discovery risk, and advance programs with confidence.
